| Bioactivity | DFO-BCN is a drug intermediate, that can be used for synthesis of PET/CT imaging agent DFO-CPC634 through click chemistry[1]. |
| CAS | 2910882-32-3 |
| Formula | C36H60N6O10 |
| Molar Mass | 736.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Miedema IHC, et al., PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients. Adv Mater. 2022 May;34(21):e2201043. |
DFO-BCN
CAS: 2910882-32-3 F: C36H60N6O10 W: 736.90
DFO-BCN is a drug intermediate, that can be used for synthesis of PET/CT imaging agent DFO-CPC634 through click chemistr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.